RIKER LAUREN
SEC CIK 1545439 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | VP, Fin | 62.3K | — | $1.88M | 28 | 2021-07-28 | 2026-06-11 |
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-12 21:07 | 2026-06-11 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | S - Sale | $23.50 | -6,115 | 62.3K | -9% | -$143.7K |
| 2026-06-05 17:57 | 2026-06-03 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $22.32 | -3,187 | 68.4K | -4% | -$71.1K | |
| 2026-02-13 | 2026-02-11 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +19.3K | 71.6K | +37% | $0 | |
| 2026-02-03 | 2026-01-30 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $20.54 | -2,751 | 56.3K | -5% | -$56.5K | |
| 2026-02-03 | 2026-02-02 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | S - Sale | $20.81 | -4,000 | 52.3K | -7% | -$83.2K | |
| 2026-01-06 | 2026-01-05 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | S - Sale | $24.24 | -1,416 | 59.1K | -2% | -$34.3K | |
| 2026-01-06 | 2026-01-02 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $24.46 | -159 | 60.5K | -0.3% | -$3,889 | |
| 2025-06-05 | 2025-06-03 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $26.40 | -3,374 | 65.1K | -5% | -$89.1K | |
| 2025-06-05 | 2025-06-04 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | S - Sale | $26.21 | -5,578 | 59.6K | -9% | -$146.2K | |
| 2025-02-04 | 2025-02-01 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +30.6K | 68.5K | +81% | $0 | |
| 2025-01-06 | 2025-01-02 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $18.33 | -159 | 37.9K | -0.4% | -$2,914 | |
| 2024-06-13 | 2024-06-12 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +21.4K | 42.0K | +103% | $0 | |
| 2024-06-13 | 2024-06-12 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | S - Sale | $28.72 | -3,970 | 38.1K | -9% | -$114.0K | |
| 2024-06-05 | 2024-06-03 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $30.89 | -1,843 | 20.7K | -8% | -$56.9K | |
| 2024-01-04 | 2024-01-02 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | SVP, Fin | F - Tax | $32.00 | -159 | 22.5K | -0.7% | -$5,088 | |
| 2023-07-07 | 2023-07-05 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.91 | -643 | 22.7K | -3% | -$25.0K | |
| DM | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.42 | -6,366 | 22.7K | -22% | -$244.6K |
| D | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | A - Grant | $0.00 | +10.0K | 29.1K | +52% | $0 |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale | $38.42 | -1,207 | 19.7K | -6% | -$46.4K |
| D | 2022-06-08 | 2022-06-06 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale | $61.37 | -1,150 | 14.0K | -8% | -$70.6K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | A - Grant | $0.00 | +5,850 | 19.9K | +42% | $0 |
| D | 2022-03-14 | 2022-03-10 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | M - OptEx | $10.81 | +9,300 | 24.5K | +61% | +$100.5K |
| DM | 2022-03-14 | 2022-03-10 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale+OE | $71.22 | -9,300 | 16.1K | -37% | -$662.3K |
| D | 2022-01-20 | 2022-01-18 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | M - OptEx | $10.81 | +2,500 | 17.7K | +16% | +$27.0K |
| D | 2022-01-20 | 2022-01-18 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | S - Sale+OE | $64.97 | -2,500 | 15.2K | -14% | -$162.4K |
| D | 2022-01-10 | 2022-01-04 | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | SVP, Fin | A - Grant | $0.00 | +2,000 | 15.2K | +15% | $0 |
| DM | 2021-07-30 | 2021-07-28+ | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | VP, Fin | S - Sale+OE | $60.85 | -2,500 | 13.2K | -16% | -$152.1K |
| DM | 2021-07-30 | 2021-07-28+ | PCRX | Pacira BioSciences, Inc. | Riker Lauren Bullaro | VP, Fin | M - OptEx | $10.81 | +2,500 | 15.6K | +19% | +$27.0K |
Purchase Sale Sale after option exercise All abbreviations